Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Portfolio Pulse from Lisa Levin
The article lists the stocks that have gained and lost the most in Wednesday's mid-day session. Among the gainers, Biodexa Pharmaceuticals, SMX, Carvana, and Panbela Therapeutics saw significant increases due to various reasons such as patent allowances, better-than-expected sales, and asset divestitures. Among the losers, Sono Group, Amarin Corporation, Aqua Metals, and Aptevo Therapeutics saw significant decreases due to reasons such as delisting notices, organizational restructuring, and public offerings.

July 19, 2023 | 5:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Amarin Corporation's stock fell 22.7% to $1.1050 after initiating an organizational restructuring program and issuing lower interim second-quarter revenues.
The stock fell significantly, indicating negative investor sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Aptevo Therapeutics' stock dipped 17.4% to $0.8999.
The stock fell significantly, indicating negative investor sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Aqua Metals' stock fell 18.3% to $1.38 after pricing a $17.4 million public offering of 15.82 million shares of common stock at a price of $1.10 per share.
The stock fell significantly, indicating negative investor sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Sono Group's stock declined 34.1% to $0.2233 after receiving a notice of delisting from the Nasdaq.
The stock fell significantly, indicating negative investor sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Biodexa Pharmaceuticals' stock rose 43% to $6.91.
The stock rose significantly, indicating positive investor sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Carvana's shares jumped 32.3% to $52.67 after reporting better-than-expected second-quarter sales and positive adj. EBITDA guidance for the third quarter.
The stock rose significantly, indicating positive investor sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Panbela Therapeutics' stock gained 29.5% to $2.68 after divesting certain assets in its eflornithine pediatric neuroblastoma program to US WorldMeds for $9.5 million.
The stock rose significantly, indicating positive investor sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
SMX's stock jumped 39.1% to $0.2031 after receiving a notice of allowance for its U.S. patent application.
The stock rose significantly, indicating positive investor sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100